Strategic partnerships KOELIS collaborates with world-renowned universities and hospitals to advance imaging innovations in MRI-ultrasound fusion for prostate interventions, presenting a channel for co-development, pilot programs, and joint marketing opportunities with research institutions and clinical centers.

Global adoption With a presence across Europe, United States, Canada, Asia-Pacific, and the Middle East and more than 300,000 patients treated, KOELIS offers access to a broad, international installed base for upsell of newer modules, upgrades, and maintenance services.

Product expansion Recent launches like ProMap Smart automatic prostate contouring and a compact 3D probe indicate a roadmap toward automated workflows and streamlined imaging, suggesting opportunities to sell complementary software licenses, hardware extensions, and workflow optimization solutions.

Clinical leadership KOELIS’ focus on reducing overtreatment and enhancing personalized care positions it well to engage hospital systems pursuing value-based care, enabling sales plays around outcome tracking, decision support, and integration with existing EMR/EHR platforms.

Event-driven Active participation in major conferences (EAU, AUA) and partnerships demonstrates ongoing visibility and demand generation potential; prioritize outreach around new product introductions, case studies, and sponsorship opportunities to accelerate buyer engagement.